This review will illustrate several under-discussed key considerations in targeted protein degradation drug discovery and development: 1) the contributing factors for the selectivity of PROTAC ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...

STOCKHOLM, SWEDEN March 13, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an ...

Mohan, chairman, Dr. Mohan’s Diabetes Specialities Centre, Chennai. “Now that the drug is going off patent, it will be prescribed more,” he said. Until the year 2000, Indian diabetologists ...

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...

When a manufacturer creates a new medication, the company applies for a product patent, which gives them ownership over the product for 20 years. For those two decades, it is prohibited by law for ...

Countries like India and Brazil which had reached high levels of indigenisation began to have their battles with drug ... development. Each chapter deals with one aspect of patents and leads ...

This innovative intersection of technology and healthcare addresses the complexities of identifying novel therapeutic compounds, accelerating the drug development timeline, and optimizing the success ...